Computational Biochemistry of Membrane Receptors
Members (researchers): Hugo Gutiérrez de Terán Castañón, Oscar Diaz Sanzo
Currently there are no tools associated with this research group.
There are no service units associated with this research group.
Computational simulation of biomolecules includes three dimensional modeling of receptors, simulation of their mechanisms of activation and elucidation of the molecular basis of their regulation by other molecules. Computational modeling has established as basic component to understand biochemistry, molecular pharmacology and designing drug-like compounds. In our lab, we have specialised in developing computational methods to answer each of this points and apply our protocols to understand the signalling mechanism of membrane receptors, with a special focus on G protein-coupled receptors (GPCRs), arguably the largest family of drug targets. Our areas of interest include i) understanding and improving regulatory mechanisms by allosteric modulation, ii) design of novel chemical space with improved pharmacological profiles, iii) development of highly efficient physics-based modeling protocols, both to screen chemical compounds and to predicting the effect of pathogenic mutations.
Analysis packages (R, Python, etc.), Applications of Computational Biology, Bioinformatics Software and Tools, Biomolecular simulation, Computational Methods, Computational models and simulations, Drug Discovery and design, Molecular Interactions/Docking, Mutation Analysis and design, Structural bioinformatics, Structure prediction, Web-service, Workflow managers
Publications
Research lines
- Development of novel polypharmacology-based cancer immunotherapy strategies targeting the purinergic signalling pathway
- Predictive models for precision modulation of G protein–coupled receptors (GPCRs): allosteric modulators and biassed agonists
- New methods to elucidate molecular effects of mutations on protein structure and function
Funding
- Adenosine Receptors in Immune-Oncology. Agencia Estatal de Investigación - Ministerio de Ciencia y Universidades. National. 01/09/2024 - 31/08/2027.
More info
Collaborating Companies: Edelris (https://www.edelris.com/)
Spin-off: Modsim Pharma (https://modsim-pharma.com/)
HPC Resources: in house - Cuelebre
DRAGO

